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ABSTRACT 
Discovery and characterization of an antibiotic from the soil bacterium Bacillus sp. 
by 
Thomas Barber 
 
Many important antibiotics have become nearly obsolete due to the rise of antibiotic resistant 
pathogens.  Rhodococcus, an actinomycete related to the prolific antibiotic producing genus 
Streptomyces, harbors over 30 genes for secondary metabolism that could be involved in 
antibiotic production.  Several antibiotics have already been reported for Rhodococcus, 
suggesting the genus may be a good source for new inhibitory compounds.  Fifty-four soil 
bacteria were isolated using enrichment culture techniques (including 37 Rhodococcus) and 
screened for antibiotic producers.  BTHX2, a species of Bacillus was found to have activity 
against Micrococcus luteus and Rhodococcus erythropolis.  BTHX2 has a 16S rDNA sequence 
97% homologous to Bacillus licheniformis, and may be a new strain of B. licheniformis.  The 
inhibitory substance produced by BTHX2 was found to have a spectrum of activity against a 
broad Gram-positive bacteria and some fungus and may have cytolytic activity. 
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CHAPTER 1 
INTRODUCTION 
The Problem of Antibiotic Resistance 
 Antibiotic resistance has been on the rise for many years.  Shortly after its introduction in 
the 1940s, microbial resistance to penicillin was reported (Infectious Diseases Society of 
America [IDSA], 2004).  However, the problem of resistance was not widespread until years 
later.  In fact, during the mid 1950s the problem of infectious diseases was considered “solved” 
(Spellberg et al. 2008).  However, during the 1970s and 1980s antibiotic resistance among 
pathogens became widespread (Demain and Sanchez 2009).  In 2004 it was estimated that 70% 
of pathogens were resistant to at least one type of antibiotic (Demain and Sanchez 2009), and 
that number has likely increased in more recent years.  In that same year the IDSA put out a call 
to action against the development of resistance in a report garnered toward the general public and 
politicians.  This report outlined the magnitude of antibiotic resistance and suggested legislative 
solutions to congress (IDSA 2004), some of which have been enacted (Spellberg et al. 2008).  
The problem of antibiotic resistance is most prevalent where antibiotic use is most prevalent – in 
hospitals, especially with nosocomial infections (Rice 2008, Boucher et al. 2009), and especially 
in intensive care units in countries with no usage restrictions (Owens 2008).  In 2008 it was 
suggested that certain pathogens responsible for a large portion of nosocomial infections receive 
federal funding for study (Rice 2008).  These pathogens were given the abbreviation “ESKAPE”, 
for Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumanni, Pseudomonas aeruginosa, and Enterobacter species. 
 There are several reasons for the drastic development of antimicrobial resistance of late.  
One example would be pharmaceutical companies pulling out of antibiotic research and 
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development to pursue more lucrative drug avenues, such as the treatment of chronic diseases 
and life style conditions (Projan 2003).  Second, the past trend of relying on semi-synthetic 
derivatives of old compounds has led to higher resistance rates.  Although semi-synthetic 
derivatives of antibiotics have served well to combat resistance, this practice simply creates 
compounds for which there are already underlying resistance mechanisms.  Third, the traditional 
low-throughput method of finding novel classes of antibiotics by random screening of soil 
microbes is not applicable to antibiotic discovery today.  During the 1940s to 1950s novel 
compounds were easily isolated from 1 in 10 or 1 in 100 randomly screened soil samples; 
Daptomycin, which was marketed in 2003 and was one of the first novel classes of antibiotics 
introduced in several decades, was isolated in 1 in ten million randomly screened actinomycetes 
(Baltz 2007).  Thus to find new antibiotics by random screening of soil bacteria, drastic (and 
laborious) high-throughput screening is required. 
 
New Methods for the Discovery of Antimicrobial Compounds 
 Old methods of developing and/or screening for new antimicrobial compounds may have 
failed thus far, but new methods employing contemporary technology are leading to the 
discovery of novel compounds with biological activity.  The most promising and powerful of 
these new methods is through genomic analysis.  Fifteen years ago, the first complete sequencing 
of a bacterial genome was reported (Bode and Müller 2005).  Today, there are nearly 1500 
completely sequenced bacterial genomes, with a further 600 bacterial genome sequencing 
projects underway (Rossolini and Thaller 2010).  The original thought was this sequence 
information would provide a plethora of novel targets for screening against synthetic chemical 
libraries (Payne et al. 2007).  The screening of a synthetic library of over 500,000 chemical 
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compounds against ~ 150 genetically identified essential targets by GlaxoSmithKline resulted in 
only 16 inhibitory compounds, none of which made it to market (Payne et al. 2007).  In contrast, 
the concept of microbial genome-mining for novel natural products with biological activity 
appears quite promising.  During the sequencing of bacterial genomes it was found that 
organisms known to produce antibiotics could produce more compounds than had been 
previously reported, as ascertained by the discovery of numerous polyketide synthase (PKS) and 
non-ribosomal peptide synthase (NRPS) gene clusters (Bode and Müller 2005, Gross 2009).  The 
sequencing of Streptomyces coelicolor identified 20 gene clusters for secondary metabolism; 
only 4 compounds were originally reported from the organism (Bode and Müller 2005).  In 
addition, the machinery for secondary metabolism was found in bacteria for which no secondary 
metabolites had ever been reported (Bode and Müller 2005).   
The concept of genomic mining is to make use of these “orphan” biosynthetic gene 
clusters.  The first step is to identify NRPSs or PKSs in a given organism of interest, using PCR.  
This is carried out with primers specific for conserved regions of these biosynthetic genes.  For 
PKSs, this involves targeting specific domains of the synthetase, including ketoacylsynthase 
domains, acyltransferase domains, and adenylation domains (Gross 2009).  Adenylation domains 
from NRPSs are also targeted for PCR (Gross 2009).  Once a gene cluster is identified there are 
several methods to find the chemical compound it produces. 
One method is to use bioinformatic prediction and screening (Gross 2009).  This method 
attempts to predict the chemical composition of the product produced by the biosynthetic 
pathway based on the different domains of the PKS or NRPS (as ascertained by sequence data).  
Thallion Pharmaceuticals Incorporated identified 10 orphan biosynthetic pathways in the known 
vancomycin producer Amycolatopsis orientalis (Gross 2009).  One PKS cluster was predicted to 
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produce a new glycosidic polyketide.  Culture broth screening revealed a compound with activity 
comparable to vancomycin which had a novel mechanism of action (Gross 2009).  Another 
method of finding natural products from orphan gene clusters is the genomisotropic approach, in 
which the microorganism is provided a substrate during fermentation that contains an isotope of 
carbon or nitrogen (Gross 2009).  Bioinformatics also comes into play with this method, as the 
chemical structure of the compound in question is predicted by tracking the isotope during 
isolation of the compound.  Genome sequencing of Pseudomonas fluorescens revealed an orphan 
NRPS that was predicted to produce a leucine-containing peptide (Gross 2009).  Orfamide A was 
discovered by providing the bacterium [
15
N] leucine during growth and was found to have 
activity against amphotercin B resistant Candida albicans (Gross 2009).  There are several other 
methods for discovering compounds through genome-mining that have also met with success.  
These include heterologous expression of the orphan gene cluster in another bacterial host, gene 
inactivation studies (by insertional mutagenesis), and the „one strain many active compounds‟ 
(OSMAC) approach, in which culture conditions are varied in an attempt to induce gene 
expression (Gross 2009). 
Another powerful tool of the post-genomics era is combinatorial biosynthesis.  
Combinatorial biosynthesis, as defined by Floss (Floss 2006), is “the application of genetic 
engineering to modify biosynthetic pathways for natural products in order to produce new and 
altered structures using nature‟s biosynthetic machinery”.  The concept of combinatorial 
biosynthesis is based on knowledge of enzyme function, as well as the structure and activity of 
PKSs and NRPSs.  In short, the modules of PKS or NRPS gene clusters are modified in an 
attempt to produce new compounds from known biosynthetic pathways.  For the field of 
antibiotic discovery this has met with moderate success.  The biosynthetic pathway of 
13 
 
erythromycin has been modified to contain more polyketide chains, and in one case complete re-
engineering of the pathway lead to the production of the antiparasitic compound megalomicin 
(Bode and Müller 2005).  However, the genetic engineering of PKS and NRPS pathways can be 
unpredictable, and often the predicted transformations do not occur or occur only at a very low 
frequency (Bode and Müller 2005, Li and Vederas 2009). 
An additional potential source of untapped antibiotics could be microbes from marine 
habitats.  This is especially true for marine actinomycetes, whose terrestrial cousins are well 
documented antibiotic producers (Liu et al. 2010).  Indeed, genome-scanning of Verrucosispora 
maris (a deep sea actinomycete) revealed over 20 orphan biosynthetic gene clusters (Liu et al. 
2010).  In addition there are over 30 compounds in clinical trials for the treatment of cancer that 
were derived from marine microbes (Liu et al. 2010).  Antibiotic compounds isolated from 
marine actinomycetes include Proximicin, Caboxamycin, and Abyssomicin (Liu et al. 2010).  It 
is predicted that there are many more novel natural products to be found in marine microbes.  
However, although many marine and soil microbes (such as the actinomycetes) can be cultured 
with standard lab media, the vast majority are „unculturable‟.  One way to overcome this obstacle 
is special enrichment culture techniques, such as the use of seawater as an ingredient in growth 
media (Liu et al. 2010).  Another enrichment technique involves a unique system of co-culture in 
which a diffusion chamber allows the passage of small molecules from a community of bacteria 
that may act as cofactors for promoting growth (Liu et al. 2010).  In this method microbes can 
grow in the diffusion chamber in the presence of other bacteria in the environment and still 
remain a „pure‟ culture (Liu et al. 2010).  In addition, application of metagenomics (acquisition 
of DNA from environmental samples, especially of unculturable microbes) is very useful, 
especially when scanning for PKSs or NRPSs.  One research group constructed a library of 
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30,000 metagenomic clones from marine microbes, of which 16 exhibited biological activity 
(Liu et al. 2010).  As more and more scientists take interest in this area of research, it is likely 
that marine microorganisms will become an important source of novel natural products. 
 
The Genus Rhodococcus 
Overview 
 Forty-five percent of medically important antibiotics have come from actinomycetes, and 
especially from the genus Streptomyces.  Considering this, it would seem that actinomycete 
bacteria are an excellent place to discover more biologically active compounds.  Indeed, there is 
an actinomycete genus related to Streptomyces that may be a source of new antibiotics: 
Rhodococcus.  The genus Rhodococcus is composed of soil bacteria widely distributed in the 
environment.  Rhodococci have been isolated from ground water, bore holes, feces, marine 
sediment, „dry‟ earth, as flora (in animals, plants and insects), as pathogens (from plants and 
animals), and from contaminated soils (Bell et al. 1998).  Rhocococci are Gram positive, aerobic, 
nocardioform organisms that begin life as a mycelium that later fractionates into rods or cocci 
(Bell et al. 1998).  One distinctive feature of Rhodococcus is strong pigmentation; on standard 
lab media coloration can range anywhere from orange, red, pink, white, cream, yellow, or even 
colorless (fig. 1) (Goodfellow 1989).  In addition the rhodococcal cell wall contains mycolic 
acids ranging from 30 – 54 carbon atoms in length, which is intermediate between 
Corynebacterium (which have shorter chains) and Mycobacterium (which have larger chains). 
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Figure 1: A plate showing pigmentation of various 
Rhodococcus isolates 
 
Pathogens from Rhodococcus 
There are 2 major pathogens in the genus Rhodococcus: R. equi and R. fascians.  
Rhodococcus equi has long been recognized as a horse pathogen but can also cause disease in a 
range of other animals (Bell et al. 1998, von Bargen and Haas 2009).  The vector of transmission 
is thought to be inhalation of aerosolized dust particles contaminated with R. equi (von Bargen 
and Hass 2009).  In the lung, R. equi causes the formation of chronic, puss-filled lung abscesses 
from which R. equi can disseminate to infect other tissues (von Bargen and Haas 2009).  
Rhodococcus equi can also infect immunocompromised humans, with the disease presentation 
seen in horses (von Bargen and Hass 2009).  Although rare, human infection with R. equi is often 
fatal. 
 Rhodococcus fascians is a plant pathogen with a broad host range encompassing 39 plant 
families and 86 genera (Goethals et al. 2001).  The bacterium causes loss of apical dominance 
and the growth of lateral shoots that develop into leafy galls (Bell et al. 1998).  Although this 
pathogen has an extensive host range including crops such as tobacco, peas, and asparagus and 
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ornamental plants such as chrysanthemum, the economic impact is not thought to be substantial 
(Bell et al. 1998, Goethals et al. 2001). 
 
Ecological Importance of Rhodococcus 
 Rhodococcus has the ability to degrade a wide range of unusual and recalcitrant organic 
pollutants in the soil (Carvalho et al. 2005).  An excellent example is the degradation of 
polyaromatic hydrocarbons (PAHs) by Rhodococcus.  First, species of Rhodococcus harbor 
many genes for oxygenases (Mcleod et al. 2006), which are able to break open the aromatic ring 
of PAHs, catalyzing the first step in the degradation of these compounds (Carvalho et al. 2005).  
Second, Rhodococcus can produce surfactants that bind to and break up hydrocarbons, making 
them more available for attack (Carvalho et al. 2005).  Lastly, mycolic acids in the rhodococcal 
cell wall act as cellular surfactants, allowing Rhodococcus to bind to oil/water interfaces and also 
allow easier passage of hydrocarbons into the cell.  In addition to bioremediation, Rhodococcus 
could be used to produce cleaner burning fuels.  Before processing, fossil fuels contain sulfur 
and can be a major cause of acid rain when burned (de Carvalho et al. 2005).  Rhodococcus 
erythropolis strain IGTS8 was found to desulfurize dibenzothiophene (DBT) and release 
inorganic sulfur (de Carvalho et al. 2005).  Dibenzothiophene desulfurization can be applied to 
fossil fuels, and the sulfur is removed without affecting carbon-carbon bonds (an ability so far 
unique to Rhodococcus) and thus the caloric value of the fuel is preserved (de Carvalho et al. 
2005).   
 Hydrolases have also been reported for Rhodococcus that can catalyze the hydrolysis of a 
number of substrates.  Most notable of these is the nitrilase enzyme of R. erythropolis strain J1, 
which catalyzes the hydrolysis of acrylonitrile to acrylamide (de Carvalho et al. 2005).  The 
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Nitto Chemistry Industry Company Ltd (Japan) uses this conversion process to produce ~ 30,000 
tons of acrylamide each year, which is the most successful application of a bacterial enzyme in 
industry ever reported (Bell et al. 1998, de Carvalho et al. 2005).   
In addition to the above described metabolism, various rhodococci have been isolated 
using a broad range of chemicals as the sole source of carbon and energy.  These include (but are 
not limited to): Explosives (Seth-Smith et al. 2008), insecticides (Jung-Bok et al. 2008), phenols 
(de Carvalho et al. 2005), benzenes (de Carvalho et al. 2005), crude oils (Ohhata et al. 2007), 
arsenic containing compounds (Nakamiya et al. 2008), polychlorinated biphenyls (de Carvalho 
et al. 2005), certain pharmaceuticals (Gauthier et al. 2010), solvents and hydrocarbons (Civilini 
2009), styrene (Tischler et al. 2009), and narcotics such as cocaine and heroin (Ascenzi et al. 
2008, Cameron et al. 1994).  
 
Genome Sequence of RHA1 
 In 2006 the genome of Rhodococcus species RHA1 was sequenced (McLeod et al. 2006).  
It was found that the genome consisted of 9.7 million base pairs, one of the largest bacterial 
genomes sequenced to date.  The genome is composed of 4 linear elements: 3 plasmids and the 
chromosome.  Of the 9,145 protein coding sequences found, oxygenases were particularly 
abundant (numbering 201 proteins, some of which were homologues to different oxygenases).  
In addition, 38.4% of the genes were coding for proteins of unknown function.  Before this 
report no secondary metabolites had been characterized for Rhodococcus.  Despite this fact, over 
30 genes for secondary metabolism were found, including 24 NRPSs and 7 PKSs, which, as 
shown previously, could be involved in antibiotic production (as well as other secondary 
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metabolites like siderophores and pigments).  In fact, several Rhodococcus species have been 
reported to produce antibiotics. 
 
Antibiotics Produced by Rhodococcus 
The first inhibitory compounds reported were the rhodopeptins, isolated from 
Rhodococcus sp. Mer-N1033 (Chiba et al. 1999).  Strain Mer-N1033 was isolated from the Iwate 
Prefecture in Japan, in a soil sample from Mount Hayachine (Chiba et al. 1999).  Rhodopeptins 
are cyclic tetrapeptides that contain a β-amino acid and 3 α-amino acids.  All 5 compounds were 
reported to exhibit strong activity against Candida albicans and Cryptococcus neoformans.  
Another interesting set of antibiotics reported from Rhodococcus are the rhodostreptomycins.  
Kurosawa et al. (2008) were growing Rhodococcus fascians 307C0 in co-culture competition 
with Streptomyces padanus which resulted in clearance of S. padanus from the culture broth.  
Subsequent genome analysis revealed that R. facians 307C0 was harboring a large segment of S. 
padanus DNA.  Further research yielded 2 compounds from R. fascians 307C0 – 
rhodostreptomycins A and B.  The authors postulate that the biosynthetic genes for the 
compounds were acquired via horizontal gene transfer (HGT) from S. padanus during co-culture.  
Interestingly, the rhodostreptomycins are aminoglycoside compounds that differ greatly from the 
actinomycin antibiotics produced by S. padanus. 
In an antibiotic screening campaign against Mycobacterium smegmatis, Iwatsuki et al.  
found Rhodococcus jostii K01-B0171 to exhibit inhibitory acivity (Iwatsuki et al. 2007).  The 
research group was able to isolate 2 compounds from K01-B0171: lariatins A and B.  These 
compounds are peptides consisting of 18 to 20 amino acids and have a lasso structure (figure 2).  
Lariatin B has a minimum inhibitory concentration (MIC) of 6.25µg/ml against M. smegmatis.  
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Lariatin A shows activity against Mycobacterium tuberculosis (MIC 0.39µg/ml) as well as M. 
smegmatis (MIC 3.13µg/ml).  Finally, 3 different quinoline compounds have been isolated from 
2 rhodococci in the form of aurachins.  Aurachin RE was isolated from R. erythropolis JCM 
6824 and is similar in structure to aurachin C type antibiotics (Kitagawa and Tamura 2008).  
Aurachin RE displays a broad spectrum of activity against Gram-positive organisms.  More 
recently aurachins R and Q were isolated from Rhodococcus sp. Acta 2259 (Nachtigall et al. 
2010).  Acta 2259 was isolated from the Milcote Pilot Sewage Treatment Plant (Stratford-upon-
Avon, United Kingdom) from activated sludge foam.  Aurachin Q was found to be inactive, and 
aurachin R exhibited minor activity against Staphylococcus epidermidis, Bacillus subtilis, and 
Propionibacterium acnes. 
 
 
Figure 2: Structure and composition of the lariatins (Iwatsuki et al. 2007) 
 
Enrichment Culture 
 These results suggest that additional bioactive compounds remain to be found in 
Rhodococcus.  However the problem with applying random low-throughput methods of 
screening soil isolates for novel compounds was discussed above.  One technique to get past that 
obstacle is to perform enrichment culturing to isolate Rhodococcus.  The first step in enrichment 
culturing is to prepare a chemically defined minimal growth medium devoid of a required growth 
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factor, such as a source of carbon.  The second step is to provide an unusual compound as the 
sole source of the required growth factor.  In this case providing hexadecane as the sole source of 
carbon and energy is an excellent example.  Hexadecane is a hydrocarbon compound that is 
similar to fuels such as gasoline and diesel, of which the biodegradation by Rhodococcus is well 
documented (Bell et al. 1998, de Carvalho et al. 2005, Ohhata et al. 2007).  The assumption is 
that most bacteria in the soil will not be able to use hexadecane as the sole source of carbon and 
energy, and thus the growth medium has enriched for smaller populations of soil bacteria that 
can use hexadecane.   
 It is advantageous to perform enrichment culture techniques to isolate species of 
Rhodococcus for two reasons.  First, as stated previously Rhodococcus is dispersed ubiquitously 
in the environment, especially in soil, and as such should be relatively easy to isolate from soil 
samples.  Second, various species of Rhodococcus have been isolated growing on a wide range 
of unusual compounds (Cameron et al. 1994, Carvalho et al. 2005, Ascenzi et al. 2008, Jung-
Bok et al. 2008, Seth-Smith et al. 2008, Civilini 2009, Tischler et al. 2009,de Gauthier et al. 
2010).  Thus it is more likely that Rhodococcus would be isolated using enrichment culturing 
than many other bacteria. 
 
The Genus Bacillus 
Overview 
 Besides actinomycete bacteria, another important source of antibiotics is the genus 
Bacillus.  Bacillus is comprised of Gram-positive, rod-shaped soil bacteria that are widely spread 
in the environment, and different species vary greatly in the specific niches they inhabit, and 
include thermophilic, mesophilic, psychrophilic, halotolerant, halophilic, alkalinophilic, 
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neutrophilic, and acidophilic organisms (Logan and De Vos 2009).  Species of Bacillus are also 
isolated from plants, animals, humans, and insects as flora and as pathogens (Logan and De Vos 
2009).  Members of the genus Bacillus are collectively referred to as “Gram-positive, aerobic 
spore-formers”, yet several are known to be facultative anaerobes, and recently some species 
were discovered that are strict anaerobes (Logan and De Vos 2009).   In addition, some species 
can be Gram-variable, Gram-negative, or even acid-fast at certain stages of their life cycle 
(Logan and De Vos 2009).  Spore formation by Bacillus is a hallmark of the genus and is 
important during identification of species in relation to spore size, shape, and position within the 
cell (Logan and De Vos 2009).   Bacterial endospores are hardy “over-wintering” structures that 
allow cells to survive harsh conditions, and are resistant to heat, chemicals, radiation, and 
dessication (Logan and De Vos 2009).  These spore characteristics make Bacillus species very 
persistent wherever they are deposited, which includes almost every environment on earth, both 
land and sea (Logan and De Vos 2009). 
 
Pathogens from Bacillus 
 Probably the most infamous pathogen of Bacillus is B. anthracis, causative agent of 
anthrax (Logan and De Vos 2009).  Anthrax is primarily a disease of herbivores,  and infection 
occurs after ingestion of B. anthracis spores from the environment.  After ingestion, the 
pathogen gains access to the lymphatic system and the spleen, where it replicates.  Within a few 
days B. anthracis causes septicemia in the afflicted animal, which is fatal.  B. anthracis can also 
infect humans and is greatly feared as a bioterrorism agent (Logan and De Vos 2009).  In 
humans infection can occur via inhalation, ingestion, or cutaneously, cutaneous transmission 
being most common (99% of cases).  Cutaneous anthrax occurs in wounds and causes the 
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formation of skin lesions but does not disseminate to other tissues.  Before antibiotic treatment 
anthrax was often fatal.  However, B. anthracis shows little resistance to penicillin, and this drug 
can effectively treat infection. 
 Other prominent pathogens from Bacillus include B. cereus and B. thuringiensis (Logan 
and De Vos 2009).  B. cereus causes two types of food poisoning: diarrheal, which is caused by 
an enterotoxin, and nauseal , which is caused by emetic toxin.  B. cereus may also cause 
opportunistic infections, including endophthalmitis (eye infection), keratitis, and wound 
infection.  B. thruingiensis is an insect pathogen, that produces parasporal bodies known as δ-
endotoxins.  The δ-endotoxins are lethal to insects and invertebrates.  
 
Ecological Importance of Bacillus 
 The genus Bacillus has been of great importance to science for many years.  Indeed, B. 
subtilis is a model Gram-positive organism in scientific studies due to its ease of isolation, 
cultivation, and manipulation in a laboratory setting (Logan and De Vos 2009).  In addition B. 
subtilis was also the first Gram-positive organism to have its genome completely sequenced 
(Logan and De Vos 2009).  Several species of Bacillus have been shown to degrade unusual 
substrates, including p-nitrophenol and 4-chlorobenzoic acid (Logan and De Vos 2009).  One 
strain of B. megaterium with an engineered cytochrome P450 is known to degrade polyaromatic 
hydrocarbons (Logan and De Vos 2009).  Some species of Bacillus may also be important in 
waste management as they have been shown to accumulate metal ions in their cell wall.  Bacillus 
has also been isolated as flora from plants, both on outer surfaces and inner tissues.  These 
organisms (termed epiphytes and endophytes) may be of importance in prevention of plant 
disease (Logan and De Vos 2009). 
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Antibiotics from Bacillus 
 The genus Bacillus has been known as an important source of antibiotic producers since 
the “golden age” of antibiotic discovery (Schaffer 1969).  Just in the organism B. subtilis, 12 
antibiotic compound have been isolated from different strains (Stein 2005).  Many of the 
antibiotics from Bacillus are peptide compounds that are synthesized either ribosomally or non-
ribosomally (by non-ribosomal peptide synthases) and are resistant to the action of proteases 
(Schaffer 1969, Nakano and Zuber 1990, Stein 2005).  Many antibiotics produced ribosomally 
are lantibiotics, which contain the unusual amino acid lanthionine (Stein 2005).  Type A 
lantibiotics are active by forming voltage-dependent pores in the cell membrane of bacteria 
(Stein 2005).  Type B lantibiotics inhibit cell wall synthesis by binding to lipid II (Stein 2005).  
Non-ribosomally synthesized antibiotics from Bacillus are often lipopeptide compounds that 
exhibit surfactant-like qualities (Stein 2005).  One of the best well-studied lipopeptides from 
Bacillus is surfactin, which is one of the most powerful surfactants known (Stein 2005).  
Surfactin can lower the surface tension of water from 72mN/m to 27mN/m and will also disrupt 
biological membranes (which is the source of its antimicrobial activity).  Polyketide antibiotics 
are also produced by Bacillus such as difficidin, which has broad-spectrum activity against 
Gram-positives and Gram-negatives.  Bacillus continues to be a good source of new antibiotics 
today, such as the recent discovery of a novel lantibiotic from B. licheniformis (Dischinger et al. 
2009). 
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Current Research 
 This thesis describes the isolation and identification of many species of Rhodococcus 
(and other bacteria) from soil samples using two enrichment techniques: carbon source 
enrichment and M3 enrichment.  Also described is the screening of the 54 identified soil isolates 
for inhibitory activity against 3 indicator strains: Rhodococcus erythropolis IGTS8, Micrococcus 
luteus, and Escherichia coli.  The results of this screening process are also discussed.  
Unfortunately, none of the screened isolates showed inhibitory activity.  However, a contaminant 
from one of the antibiotic screening assays was found to have inhibitory activity.  This organism 
was identified as a species of Bacillus, and the substance it produces was found to exhibit 
activity against a wide range of Gram-positive organisms, as well as having antifungal and 
possibly cytolytic properties.  The partial characterization of this organism and the compound it 
produces are described. 
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CHAPTER 2 
MATERIALS AND METHODS 
Soils 
„Clean‟ soils were collected from several sites around the northeast Tennessee/ETSU 
region, including Winged Deer Park, the ETSU campus, the Johnson City area off campus, and 
from several locations in the neighboring town of Kingsport.  In addition several „clean‟ soils 
were donated from Alaska, Australia, and Aruba.  „Contaminated‟ soils were also collected from 
Embreeville, TN, Butler, TN, Johnson City, TN, and Kingsport, TN.  In Embreeville, an 
abandoned Mobil gas station had a diesel storage tank that had been leaking diesel into the 
surrounding soil.  In Butler there was a gas station with a similar situation, with the gasoline 
storage tank leaking gasoline into the surrounding soil.  Soil samples from these sites were used 
for hexadecane enrichment.  In Johnson City there were two sites of contaminated soils: Sinking 
Creek and a coal pile on campus.  Sinking Creek had been contaminated with trichloroethylene 
(TCE) via runoff from an adjacent industry.  Although this happened many years prior, soil was 
still collected for TCE enrichment.  Soil was collected near the coal pile on campus for 
hexadecane enrichment.  Similarly, soil was collected from around and underneath a coal pile in 
Kingsport for hexadecane enrichment.  Soils were collected in plastic containers on site and 
stored at 4˚C until use. 
 
Growth Media 
There were several types of growth media used during this research: 
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A. Basal Salt Medium. 
 To prepare the basal salt medium, 3 different solutions need to be prepared: Na2HPO4 
solution, KH2PO4 solution, and the agar solution.  These solutions are autoclaved separately and 
are mixed after cooling in a 50 ˚C water bath.  The preparation of these solutions is as follows: 
 1.) Na2HPO4 solution   5.11g in Na2HPO4 180 ml of dH2O       
 
 2.) KH2PO4 solution   1.9 g KH2PO4 in 70 ml of dH2O 
        
 3.) Agar solution    7.5 g Bacto Agar in 235 ml of dH2O 
 
 4.) Autoclave separately, then cool in a 50 ˚C water bath before mixing 
 
 
After mixing of the first 3 solutions, there are 3 other ingredients to add:  
 
 1.) NH4Cl stock solution (20%) 5 ml 
 
 2.) MgCl2 stock solution (4%) 5 ml 
 
 3.) Hutner‟s minerals   5 ml 
 
 These 3solutions should be prepared, autoclaved, and ready for use before the preparation 
of the first 3 solutions.   
Hutner‟s Minerals 
 1.) dH2O   95 ml 
2.) Nitrilotriacetic acid  1 g 
 3.) MgCl2*6H2O  2.44 g 
 4.) CaCl2*2H2O  0.334 g 
 5.) FeCl2*4H2O  8 mg 
 6.) (NH4)6Mo7O24*4H2O  0.9 mg 
 7.) Hutner‟s salts   5 ml 
 8.) Autoclave 
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Hutner‟s Salts 
 1.) dH2O   100 ml 
 2.) EDTA*Na2 salt  0.25 g 
 3.) ZnCl2    0.52 g 
 4.) FeCl2*4H2O  0.36 g 
 5.) MnCl2*4H2O  0.20 g 
 6.) CaCl2*2H2O  0.03 g 
 7.) Co(NO3) 2*6H2O  0.25 g 
 8.) Na2B4O7*4H2O  0.02 g 
 9.) add a few drops of 1M HCl to stabilize the solution 
 10.) Autoclave 
All ingredients are mixed and autoclaved in the same container.  After mixing, a few drops of 
low concentration HCl should be added to stabilize the solution. 
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B. Bushnell – Haas (BH) medium 
 1.) dH2O  500 ml 
 2.) KH2PO4   1 g 
 3.) K2HPO4   1 g 
 4.) NH4NO3   1 g 
 5.) MgSO4*7H2O 0.2 g 
 6.) FeCl3   0.05 g 
 7.) CaCl2*2H2O 0.02 g 
 8.) Agar  7.5 g 
 9.) Bring to a gentle boil, then autoclave 
 
C. Rich Medium (RM) 
 1.) dH2O  500 ml 
 2.) Glucose  5 g 
 3.) Nutrient Broth 4 g 
 4.) Yeast Extract  0.25 g 
 5.) Agar  7.5 g 
 6.) Autoclave 
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D. M3 medium 
 M3 (Rowbotham and Cross 1977) is the most difficult growth medium to make of all the 
others used.  It consists of 5 different solutions:  
 Solution 1  0.446 g of KH2PO4 and 0.732 g of Na2HPO4 in 100 ml of dH2O 
 Solution 2  0.10 g of KNO3 and 0.29 g of NaCl in 100 ml of dH2O 
 Solution 3  0.02 g of CaCO3 in 100 ml of dH2O 
 Solution 4  0.20 g of Na propionate in 100 ml of dH2O 
 Solution 5   9 g of agar in 100 ml of dH2O 
All of these solutions need to be prepared and autoclaved separately and mixed after 
cooling in a 50 ˚C water bath.  After mixing, there are a number of other ingredients to add to the 
medium.  They are as follows: 
1.) MgSO4*7H2O stock solution (30 %) 165 µl  
2.) FeSO4*7H2O stock solution (0.001 %) 10 µl 
3.) ZnCl stock solution (2.6 %)  3.5 µl  
4.) MnSO4*4H2O (0.01 %)   100 µl 
5.) Thiamine HCl (0.4 %)   0.5 ml 
6.) Cycloheximide    50 mg 
Stock solutions of the first 5 ingredients should be prepared, autoclaved, and ready for 
use before preparation of M3 medium.  Cycloheximide can be added in solid form directly after 
cooling and mixing of solutions 1 – 5. 
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Enrichment Culture 
Two types of enrichment culturing were carried out: carbon source enrichment (for 
contaminated soils) and M3 enrichment (for „clean‟ soils).   
 
Carbon Source Enrichment Culture 
Carbon enrichment culturing was carried out with a modified version of hydrocarbon 
enrichment by Peng et al. (Peng et al. 2006).  Two different compounds were used: 
trichloroethylene (TCE) and hexadecane.  Trichloroethylene is an industrial grade solvent that is 
highly toxic to living organisms.  Hexadecane is a long chain hydrocarbon compound that is 
similar in structure to fossil fuels such as gasoline and diesel.  Cultures were started by adding 10 
ml of either BSM or BH medium to a small 50 ml Erlenmeyer flask. For TCE enrichment, BSM 
was used as the growth medium.  For hexadecane enrichment, BH was used.  Also, 1 gram of 
soil sample was added to the flask, along with 10 µl of TCE or hexadecane (giving the carbon 
source a final concentration of 0.1%).  Reagent grade (~99% purity) carbon compound was 
added undiluted to the culture.  Flasks were incubated for 7 days in a 30 ˚C water bath with 
shaking.  At the end of 7 days flasks were removed from the water bath and the soil was allowed 
to settle to the bottom of the flask.  Subculturing was carried out by drawing 1 ml from the 
settled culture and transferring to a 50 ml flask with 10 ml fresh growth medium and 0.1 % 
carbon source, which was then incubated for a further 7 days in a 30 ˚C water bath with shaking.  
This process was repeated 3 more times for a total of 4 subcultures, at which time 100 µl was 
transferred from the last subculture onto a plate composed of the same minimal medium, and 
streaked or spread out.  Due to the volatile nature of both TCE and hexadecane, the carbon 
source was supplied on the plates by soaking a small square 2 cm X 2 cm piece of Whatman‟s 
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3mm chromatography paper in the compound. The paper was then placed on the lid of the petri 
dish such that when the plate was sealed the bacteria could use the gas phase of the compound as 
a source of carbon and energy.   Isolated colonies that arose on the plates were transferred to RM 
plates for purification by several rounds of streak plating.  Organisms on RM plates were Gram 
stained to check for Gram positive rods or cocci and to check for purity.  Purity was determined 
usually by the presence of only 1 cell type in 8 optical fields at 100X magnification.  However, 
as some rhodococci can fragment into both rods and cocci purity was also ascertained by 
observation of a single colony morphology on streak plates. 
 
M3 Enrichment Culture 
For M3 enrichment, a 1:10 dilution of the soil sample was prepared by placing 1 g of soil 
sample in 9 ml of sterile distilled water in a large tube.  This suspension was then heat shocked 
rigorously by placing the tube in a 55 ˚C water bath for 6 minutes.  The soil sample was then 
allowed to cool at room temperature, mixed by vortexing, and 100 µl spread onto M3 plates.  M3 
plates were incubated on the bench top at room temperature for 1 week or until colonies arose.  
Rhodococcus is most easily identified by the vibrant pigments displayed on plates: red, white, 
orange, yellow, cream, and even colorless variants have been observed.  M3 plates were 
examined for colonies exhibiting these types of pigments.  Pigmented colonies and mucoid 
colonies were streaked on to RM plates for purification and checked by Gram stain for Gram 
positive rods or cocci. 
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Identification of Soil Isolates 
Once the purity of an isolate was confirmed, identification of the organism was carried 
out by colony PCR of its 16S rDNA gene.  Table 1 shows the composition of each PCR reaction. 
 
Table 1: List of reagents and quantities used for PCR of 16S rDNA 
PCR reaction 
dH2O 22 µl 
10x PCR Buffer (Go Taq Flexi, Promega) 10 µl 
25mM MgCl2 (Promega) 3 µl 
10mM deoxynucleotide triphosphate mix (Promega) 1 µl 
10x Enhancer (Eppendorf) 10 µl 
DNA template (single colony) 1 µl 
20 µM Forward primer (63f or Bact 8f)
A 1.25 µl 
20 µM Reverse primer (1387r or Bact 1510r)
A 1.25 µl 
Taq polymerase (Go Taq Flexi, Promega) 0.5 µl (2.5 units) 
Total volume of reaction 50 µl 
A: Forward primer 63f was used in conjunction with 1387r (Marchesi et al. 
1998), while Bact 8F (Rivas et al. 2001) was used in conjuction with Bact 
1510R (Nagashima et al. 2003). 
 
Colony PCR was carried out by picking a single colony from a fresh streak plate (2 to 3 
days old, or until fresh colonies had formed).  The colony was dispersed in 10 µl of dH2O in a 
1.5 ml Eppendorf tube by vigorously rotating the tip of the loop in the bottom of the tube.  This 
cell suspension then served as the DNA template for the PCR reaction.   The sequences of the 
primers are as follows: 63f (Marchesi et al. 1998) (5‟-CAGGC CTAACACATGCAAGTC-3‟); 
Bact 8f (Rivas et al. 2001)(5‟-AGAGTTTGATCCTGGCTCAG-3‟); 1387r (Marchesi et al. 
1998) (5‟-GGGCGGWGTGTACA AGGC-3‟); Bact 1510R (Nagashima et al. 2003) (5‟-
CGGTTACCTTGTTACGACTT-3‟).  PCR reactions were cycled under the following 
conditions: 1) 95 ˚C for 3 minutes, 2) 95 ˚C  for 1 minute, 3) 55 ˚C  for 1 minute, 4) 72 ˚C  for 2 
minutes, 5) repeat steps 2 – 4 for 29 cycles, 5) 72 ˚C  for 5 minutes.  The PCR reactions were 
first checked on agarose gels, then purified using the GeneClean Turbo kit.  Purified reactions 
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were sent to the University of Tennessee Department of Molecular Biology for sequencing.  
Sequence data was received as .seq and .ab1 files via email.  The .ab1 chromatogram files were 
examined using the program Chromas.  The DNA sequence was exported from Chromas to 
Microsoft Word, for manipulation.  “Good” was defined using Chromas as nucleotides that had a 
single strong peak with no overlapping peaks.  „Bad‟ quality sequence was defined as more than 
one peak occupying a space for a single nucleotide or multiple nucleotides in a single peak.  The 
code from the forward and reverse primers for the same organism was spliced together in Word 
in fasta format and submitted to Ribosomal Database Project (http://rdp.cme.msu.edu) for 
identification to the genus level.  Sequence data were submitted under the “sequence match” 
query on this website.  This procedure compares the sequence data to an online database of 16S 
rDNA, and will identify an organism from the Domain level down to the genus, and will give a 
list of possible species for the organism based on the percentage of homology to other sequences 
in the database. 
 
Maintenance of Cultures 
Isolates identified by 16S rDNA sequence were transferred from plates to RM slants and 
stored at 4 ˚C until use.  Rhodococcus erythropolis, Micrococcus luteus, and Escherichia coli 
were used as indicator strains during screening for antibiotic activity.  Rhodococcus erythropolis 
was maintained on RM plates.  Micrococcus luteus was maintained on BHI plates;  Escherichia 
coli was maintained on LB plates.  All indicators were stored at 4 ˚C until use, and were 
transferred to fresh medium monthly. 
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Screening for Antibiotic Activity 
Processing of microbial extracts was carried out according to the method of Garcia et al. 
(Garcia et al. 2009).  Seed cultures were prepared from the isolates in 2.5 ml RM broth in test 
tubes and grown for 1 to 2 days.  Next, 100 µl of the seed culture was used to inoculate a cotton-
stoppered 250 ml Erlenmeyer flask containing 50 ml of RM broth and 1 g of XAD-16 Amberlite 
adsorbent resin (final concentration of 2%).  The resin was weighed and transferred into the 
flasks aseptically right before inoculation.  Cultures were grown for 8 days at 30 ˚C with 
shaking.  After the culture period a turbidity reading was taken using a Klett colorimeter (red 
filter), then cultures were streaked out on RM plates to check for purity.  The cultures were 
poured into oakridge tubes and centrifuged to collect the cells and resin.  The supernatant was 
collected in a 50 ml polystyrene tube from which 1 ml was filtered into a small 1.5 ml eppendorf 
tube to be tested for antibiotic activity.  Next, 7.5 ml acetone and 7.5 ml methanol (a 50:50 ratio) 
was added to the pellet in the oakridge tube, which was then vortexed to break up the pellet.  
This slurry was poured into a small beaker then extracted with a stir bar for 15 minutes.  The 
extract was poured into an oakridge tube, and 7.5 ml of methanol + 7.5 ml of acetone were added 
to the resin + cells in the beaker for a second extraction with stirring.  The second extract was 
poured into the same oakridge tube, which was then centrifuged to collect any leftover cells 
and/or resin.  The extract was then passed through a syringe filter (0.45 µm) to remove any 
stubborn cell fragments or other artifacts and collected in a 50 ml polystyrene tube.  Tubes 
containing 30 ml of extract were then balanced and placed in a Labcono Centrivap for 
evaporation to dryness (complete drying of the extracts typically took ~ 48 hours).  After drying, 
1 ml of methanol was added to the extracts and then vortexed to re-dissolve the dried pellets.  To 
test for inhibitory activity, 25 µl of extract or supernatant was applied to a paper disk and 
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allowed to dry, before applying another 25 µl (bringing the total volume on the disk to 50 µl).  
Paper disks were created using a hole-punch on thick Whatman blot paper GB004, and sterilized 
by autoclaving.  Disks were allowed to dry completely before use in the antibiotic activity assay. 
 
Preparation of Indicator Plates for Antibiotic Assay 
To prepare indicator strains for antibiotic screening, seed cultures were grown overnight 
in 2.5 ml MH broth in test tubes.  The seed cultures were then vortexed to evenly disperse the 
cells in the medium, and dilutions were prepared in separate tubes containing 2.5 ml MH broth.  
Cultures were diluted by transferring 100 µl from the final culture into the fresh medium until 
the fresh medium had reached the same turbidity as a 0.5 McFarland Standard.  Next, a sterile 
cotton swab was inserted into the dilution tube and rotated until air bubbles were no longer 
released.  Excess fluid was removed by pressing the cotton swab on the side of the tube.  Next, 
the cotton swab was used to inoculate an MH plate by starting at the plate edge spreading the 
inoculum over 1/3
rd
 of the plate, rotating to the next uninoculated section, and repeating the 
process until the whole plate was covered.  Finally, the swab was dragged around the perimeter 
of the plate to ensure full coverage.  After the plates had dried, paper disks containing extract or 
supernatant were added, and the plates were incubated at the appropriate temperature (30 ˚C for 
48 hours for R. erythropolis, 37 ˚C for all other organisms).  After the incubation period, the 
plates were examined for zones of growth inhibition.  For any isolates that exhibited a zone of 
growth inhibition the preparation of extracts and antibiotic assay was repeated to ensure 
consistency. 
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Large Scale Isolation of Inhibitory Compounds 
 To scale up antibiotic production 2.8 L Fernbach flasks containing 1 L of RM broth and 
20 g of XAD-16 Amberlite resin were inoculated with 20 ml of a 100 ml overnight seed culture 
of BTHX2.  These flasks were grown with shaking for 4 days at 30
o
 C.  After 4 days, the cultures 
were streaked on RM plates to check for purity and a turbidity reading was taken with a Klett 
colorimeter.  If the Klett reading was approximately 130, the culture broth was separated from 
the resin using a 212 µM sieve, and a 50 ml aliquot of the broth was saved in a 50 ml polystyrene 
tube for antibiotic testing.  Next, resin from all 5 L (~ 100 g) was collected in a large 4 L beaker 
and extracted twice with 750 ml methanol and 750 ml acetone for 1 hour.  The extract was then 
collected (without transferring the resin) in 250 ml centrifuge bottles.  The extract was then 
centrifuged for 10 minutes at 4000 x g, and vacuum filtered using a 0.45µm HVHP type 
Millipore filter.  The filtered extracts were transferred to a 2 L round bottom flask and 
evaporated to a small volume using a Büchi Rotavapor R-200.  As the volume of the extract 
reduced, more extract was added to the flask until all 3 L was reduce to ~ 40 ml.  The 40 ml of 
extract was divided into two 50 ml polystyrene tubes and evaporated to dryness with a Labcono 
CentriVap.  The dried extract was brought up in 40 ml dH2O, and 50 µl of supernatant from the 
cultures and extract from the resin was tested on disks with M. luteus as an indicator strain to 
ensure production and location of inhibitory activity (activity was always found to be in the 
extract).  Next, the extract was run through an Amberlite XAD-16 column for partial 
purification, before passage through a Sephadex LH-20 column for further purification. 
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Amberlite XAD-16 Column Purification 
 The extracts derived from the methods used in this research contain a large amount of 
extraneous compounds in addition to the desired inhibitory compounds.  To „clean-up‟ the 
extract before passage through a Sephadex LH-20 column, it was passed through an XAD-16 
column.  XAD-16 resin was prepared by soaking 160 g in 1 L of ddH2O overnight to allow the 
resin to soak up water.  The next day all the dried resin at the top of the water was removed using 
a plastic 3 ml transfer pipet.  The resin was packed into a 3 X 50 cm column to give a bed 
volume of 255 ml.  To wash the resin, 3 bed volumes of methanol was passed through the 
column, which was then equilibrated with 4 bed volumes of ddH2O.  For partial purification, the 
entire volume of the extract (~ 40 ml) was poured directly into the column.  Four bed volumes of 
ddH2O was passed through the column (and saved in a clean beaker).  Next, the extract was 
eluted from the resin with 650 ml methanol collected in 50 ml fractions.  To determine which 
fractions contained inhibitory activity, 75 µl of each fraction was applied to paper disks, which 
were placed on an MH plate with M. luteus as an indicator strain.  Those fractions showing 
inhibitory activity were evaporated to dryness in a Labcono Centrivap and dissolved in 10 ml 
methanol.  The pooled fractions were then centrifuged at 9400 x g for 10 min to remove any 
precipitants, and the supernatant saved into a fresh 50 ml polystyrene tube. 
 
Sephadex LH-20 Column Purification 
Extract that had been partially „cleaned‟ by passage through an XAD-16 column was 
further purified by passage through a sephadex LH-20 column that was prepared as described by 
Wright (2009).  Briefly, a 5 ml aliquot of extract was poured directly onto the LH-20 resin, 
which separates compounds based on hydrophobicity and size.  The column was run with 
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methanol as the mobile phase, and 47 fractions were collected in 175 drop aliquots using a Bio-
Rad 2110 fraction collector.  Next, 25 µl of each fraction was applied to a paper disk and placed 
on an MH plate with M. luteus as an indicator strain.  Plates were incubated overnight, during 
which the fractions from the LH-20 column were stored at 4 
o
C.  The plates were examined for 
inhibitory activity the next day.  Those fractions that were positive were pooled in such a manner 
that precipitants that had formed overnight were left behind in the fraction tubes.  The pooled 
fractions were then evaporated to dryness in a Labcono CentriVap and reconstituted in 2 ml of 
dH2O.  This partially purified extract was then used for HPLC and bioassays. 
 
High Pressure Liquid Chromatography Purification 
Part of the LH-20 purified extract was further purified using high pressure liquid 
chromatography (HPLC).  A 2 ml aliquot of the extract was diluted with 2 ml of dH2O and 9 ml 
of methanol, yielding a 70% methanol solution.  This solution was then passed through a BioRad 
Biologic Duoflow HPLC using a Waters 7.8 mm x 300 mm Novapak HR C18 hydrophobic 
column as the stationary phase.  Deaerated dH2O (buffer A) and deaerated methanol (buffer B) 
were used as the mobile phase.  A total of 2 ml extract was loaded onto the column via 3 
consecutive 0.7 ml injections.  For each run, the UV detector was set to 254 nm, and a 
chromatogram file was produced showing absorbance of the various compounds in the extract.  
Because the inhibitory compound was unidentified, 100 µl of every other fraction of the 90 
fractions collected for each run was tested for antibiotic activity, regardless of absorbance peaks.  
The antibiotic activity of the fractions was then compared to the chromatogram file to determine 
the gradient of methanol:water that provided the best separation of the inhibitory compound from 
impurities in the extract. 
39 
 
Amino Acid Analysis by Thin Layer Chromatography 
 Acid hydrolysis was carried out by mixing an equal volume of 6 M HCl with a small 
aliquot (200 µl) of HPLC purified material and autoclaved at 121
o
C for 6 ½ hours.  The acid 
hydrolyzed material was spotted onto the TLC plate using silica gel as the stationary phase along 
with amino acid standards.  Standards of the 20 amino acids plus ornithine were prepared by 
mixing 1 mg of amino acid with 1 ml of ddH2O.  The spots were allowed to dry completely 
before placing the TLC plate in a chamber with the solvent system propanol:water (70:30) 
(Storey 2005).  The solvent was allowed to migrate up the plate until ~ 1 cm from the top, at 
which point the plate was removed from the chamber.  The TLC plate was then sprayed with 
0.25% ninhydrin, dried at room temperature, then sprayed with 0.1% n-cyanoguanidine, and 
developed at 55
o
C until spots had formed (Storey 2005).   
 
Characterization of the Inhibitory Material 
Extract that had been passed through the LH-20 column twice was brought up in 2 ml of 
dH2O, yielding 2.875 ml of extract.  Eight hundred seventy-five microliters of the extract was 
saved for the purpose of characterizing the compound.  To test its spectrum of activity, 25 µl of 
extract was applied to paper disks and allowed to air dry.  The disks were then placed on plates 
containing the following laboratory indicator strains: Klebsiella pneumoniae, Enterobacter 
aerogenes, Enterococcus faecalis, Streptococcus pyogenes, Streptococcus pneumoniae, 
Streptococcus agalactiae, Streptococcus mutans, Staphylococcus aureus, Staphylococcus 
saprophyticus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Pseudomonas 
denitrificans, Citrobacter freundii, Proteus vulgaris, Salmonella typhi, Salmonella arizoniae, 
Shigella dysenteriae, Shigella boydii, Shigella sonnei, Lactobacillus lactis, Bacillus subtilis, 
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Bacillus megaterium, Bacillus licheniformis, Neiserria subflava, Alcaligenes faecalis, Serratia 
marcesens, Corynebacterium diphtheria, Clostridium sporogenes, Mycobacterium smegmatis, 
Aspergillus niger, Penicillium notatum, Candida albicans, and Saccharomyces cervisiae. Several 
bacterial species that were isolated during enrichment culturing were also used as indicator 
strains.  L. lactis, S. epidermidis, and S. mutans seed cultures were grown on brain-heart infusion 
(BHI) broth and tested on BHI plates.  All other organisms were grown in MH broth (for seed 
cultures) and tested on MH plates.  Seed cultures were grown overnight and diluted to a 0.5 
McFarland standard before inoculation onto plates using a sterile swab.  Paper disks containing 
25 µl of LH-20 column purified extract were placed in the middle of the plates after inoculation, 
and incubated overnight or until bacterial growth was clearly seen.  Any plates containing zones 
of growth inhibition were photographed and the zone of inhibition measured and recorded. 
 
Characterization of Isolate BTHX2 
Characterization of the Bacillus organism found to produce inhibitory activity was 
carried out using various assays as described in the most recent edition of Bergey‟s manual of 
systematic bacteriology.  These tests included Gram-staining, spore staining, fermentation of 
fructose, glucose, arabinose, trehalose, and xylose; the hydrolysis of starch, gelatin, and urea; use 
of citrate; growth at 4, 24, 37, and 55 
o
C;  growth in 2, 5, 7, and 10% NaCl; and growth at 5, 6, 7, 
8, 9, and 10 pH.  Sugar fermentation was carried out using 4 ml purple broth base supplemented 
with 1 ml of a 10% solution of the appropriate sugar (mentioned above).  The NaCl and pH 
plates were prepared using Bacto Nutrient Agar as the growth medium. Spore staining was 
carried out by covering the slide with malachite green dye and heating until the dye steamed for 
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1 minute.  The malachite green was then washed off, and safranin used as a counter stain before 
observation with a microscope. 
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CHAPTER 3 
RESULTS 
Carbon Source Enrichment Culture 
For Sinking Creek soil TCE was used as the only source of carbon in an enrichment 
culturing experiment.  This yielded 5 Gram-positive isolates identified by 16S rDNA sequence 
analysis (table 2).  The TCE enrichment gave a poor yield of the target bacterium: only 1 
Rhodococcus along with 3 Arthrobacter and an Aeromicrobium.  In contrast, hexadecane 
enrichment of hydrocarbon polluted soils gave an excellent yield of rhodococci: Out of 12 
isolates, 11 were Rhodococcus and the remaining isolate (a member of the genus Gordonia) is a 
close relative to Rhodococcus (table 2). 
Table 2: Isolates recovered from hexadecane and TCE carbon source enrichment. 
Soil Source Enrichment Pigmentation Genusa Designationb 
Sinking Creek TCE Cream Arthrobacter SCTEC2 
Sinking Creek TCE Yellow Arthrobacter SCTEY2 
Sinking Creek TCE Clear Aeromicrobium SCTEC3 
Sinking Creek TCE Orange Rhodococcus SCTEO3 
Sinking Creek TCE Yellow Arthrobacter SCTEY3 
Old Coal Pile (ETSU) Hexadecane Pink Rhodococcus OCHXP1 
Embreeville Hexadecane Orange Rhodococcus EMHXO1 
Embreeville Hexadecane Light Orange Gordonia EMHXO2 
Embreeville Hexadecane Cream/Orange Rhodococcus EMHXC1 
Embreeville Hexadecane Cream/Orange Rhodococcus EMHXC2 
Kingsport Coal Hexadecane Cream Rhodococcus KCHXC3 
Kingsport Coal Hexadecane White Rhodococcus KCHXW3 
Kingsport Basement Hexadecane White Rhodococcus BMHXW5 
Kingsport Basement Hexadecane Mucoid Rhodococcus BMHXM5 
Butler, TN Hexadecane cream Rhodococcus BTHXC2 
Butler, TN Hexadecane cream Rhodococcus BTHXC6 
Butler, TN Hexadecane Cream Rhodococcus BTHXC10 
a: The genus of an isolate was derived by comparing the 16S rDNA sequence data to an online data base at 
http://rdp.cme.msu.edu.  b: for designation: the first 2 letters pertain to the soil source, the second 2 letters are the 
enrichment used, the last letter is pigmentation, and the number is the order of isolation. 
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M3 Enrichment Culture 
M3 enrichment culture proved to be a very successful method of isolating Rhodococcus 
from soil samples (figure 3).  M3 enrichment using 6 local soils yielded 17 Gram-positive 
isolates.  Eleven of these isolates were Rhodococcus, along with 3 Gordonia and 1 
Mycobacterium, both of which are closely related to Rhodococcus (table 3).  Other unrelated 
species include a Cellulomonas and an Agromyces. 
In addition to local soils, several soils from exotic locations were used with M3 
enrichment culturing, including soil from Africa, Alaska, and Aruba.  M3 enrichment with these 
soils yielded 19 isolates, including 11 Rhodococcus, 3 Arthrobacter, 1 Methylobacterium, and 1 
Micrococcaea (table 4). 
 
Table 3: Isolates recovered by M3 enrichment of local soils 
Soil Source Enrichment Pigmentation Genusa Designationb 
Winged Deer Park M3 (HEAT) Dark Pink Rhodococcus WDM3P2 
Winged Deer Park M3 (HEAT) Dark Orange Gordonia WDM3O11 
Winged Deer Park M3 (HEAT) Light Pink Rhodococcus WDM3P13 
Winged Deer Park M3 (HEAT) Cream/Pink Rhodococcus WDM3P18 
Winged Deer Park M3 (HEAT) White Rhodococcus WDM310A 
Winged Deer Park M3 (HEAT) White Rhodococcus WDM310A1 
Winged Deer Park M3 (HEAT) Orange Gordonia WDM3O5 
Winged Deer Park M3 (HEAT) Orange Rhodococcus WDM3O7A 
Winged Deer Park M3 (HEAT) Yellow Cellulomonas WDM3Y6 
Winged Deer Park M3 (HEAT) Orange Gordonia WDM3O10B 
Kingsport Ditch M3 (HEAT) Cream Rhodococcus DSM3C1 
Kingsport Ditch M3 (HEAT) Cream Rhodococcus DSM3C2 
Basement Drain Exit M3 (HEAT) Cream/Yellow Rhodococcus BEM3C1 
Basement Drain Exit M3 (HEAT) Yellow Agromyces BEM3Y1 
Sinking Creek M3 (HEAT) Light Orange Rhodococcus SCM3O11 
Butler, TN M3 (HEAT) White/Yellow Rhodococcus B1M3W4 
Embreeville M3 (HEAT) Orange/Yellow Mycobacterium EM3O3 
a: The genus of an isolate was derived by comparing the 16S rDNA sequence data to an online data base at 
http://rdp.cme.msu.edu.  b: for designation: the first 2 letters pertain to the soil source, the second 2 letters are the 
enrichment used, the last letter is pigmentation, and the number is the order of isolation. 
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Figure 3: M3 plate showing pigmented colonies 
 
 
Table 4: Isolates recovered from M3 enrichment of exotic soils 
Soil Source Enrichment Pigmentation Genusa Designationb 
Aruba M3 (HEAT) Cream/White Rhodococcus ASM3W2 
Africa, Mali M3 (HEAT) Red Rhodococcus A2M3R1 
Africa, Mali M3 (HEAT) White Micrococcaea A1M3W6 
Africa, Mali M3 (HEAT) White Arthrobacter A1M3W5 
Africa, Mali M3 (HEAT) Cream/Clear Rhodococcus A2M3C2 
Africa, Mali M3 (HEAT) Orange Rhodococcus A2M3O7 
Africa, Mali M3 (HEAT) Red Rhodococcus A2M3R1 
Africa, Mali M3 (HEAT) red Methylobacterium A1M3R4 
Africa, Mali M3 (HEAT) Orange Rhodococcus A2M3O6 
Alaskan Soil (cliffside) M3 (HEAT) Cream Rhodococcus ACM3C1 
Alaskan Soil (cliffside) M3 (HEAT) Small White Rhodococcus ACM3W1 
Alaskan Soil (cliffside) M3 (HEAT) Small White Rhodococcus ACM3W5 
Alaskan Soil (cliffside) M3 (HEAT) Orange Rhodococcus ACM3W7 
Alaskan Soil (cliffside) M3 (HEAT) Small Cream Rhodococcus ACM3C8 
Alaskan Soil (cliffside) M3 (HEAT) Orange Rhodococcus ACM3O13 
Alaskan Soil (cliffside) M3 (HEAT) White Arthrobacter ACM3W16 
Alaskan Soil (cliffside) M3 (HEAT) Clear/Cream Rhodococcus ACM3W17D 
Alaskan Soil (cliffside) M3 (HEAT) White Rhodococcus ACM3W20 
Alaskan Soil (Glacier) M3 (HEAT) Yellow Arthrobacter AGM3Y4 
a: The genus of an isolate was derived by comparing the 16S rDNA sequence data to an online data base at 
http://rdp.cme.msu.edu.  b: for designation: the first 2 letters pertain to the soil source, the second two letters are the 
enrichment used, the last letter is pigmentation, and the number is the order of isolation. 
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Screening for Antibiotic Activity 
 All isolates identified by 16S rDNA sequence were screened for antibiotic activity (tables 
5 and 6).  EMHXC2, which was isolated from hexadecane enrichment, initially exhibited strong 
inhibitory activity against M. luteus.  However, this activity was unable to be reproduced.  
Several attempts were made to „induce‟ production of the inhibitory compound, including 
culturing with diluted RM broth (1/2 and 1/10 normal nutrient concentration), LB broth, BH with 
0.1% hexadecane as the sole carbon source, BSM containing 10 µM phosphate, and extending 
the culturing time to 8 days.  EMHXC2 exhibited weak inhibitory activity against R. erythropolis 
after culturing for 8 days.  This activity was more pronounced when EMHXC2 was cultured in 
LB broth.  The initial activity in the culture extract against M. luteus was finally attributed to 
Table 5: Antibiotic screening of isolates derived from TCE/hexadecane enrichment. 
Test Isolate M. luteus E. coli R. erythropolis 
SCTEC2 - - - 
SCTEY2 - - - 
SCTEC3 - - - 
SCTEO3 - - - 
SCTEY3 - - - 
OCHP1 - - - 
EMHXO1 - - - 
EMHXO2 - - - 
EMHXC1 - - - 
EMHXC2 - -   -
w
 
KCHXC3  -  - - 
KCHXW3 - - - 
BMHXW5 - - - 
BMHXM5  -  - - 
BTHXC2 - - - 
BTHXC6 - - - 
BTHXC10 - - - 
w: Weak growth observed around disk 
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Table 6: Antibiotic screening of isolates derived from M3 enrichment. 
Test Isolate Indicator Strain 
  M. luteus E. coli R. erythropolis 
WDM3P2 - - - 
WDM3O11 - - - 
WDM3P13 - - - 
WDM3P18 - - - 
WDM310A - - - 
WDM310A1 - - - 
WDM3O5 - - - 
WDM3O7A - - - 
WDM3Y6 - - - 
WDM3O10B - - - 
DSM3C1 - - - 
DSM3C2 - - - 
BEM3C1 - - - 
BEM3Y1 - - - 
SCM3O11 - - - 
B1M3W4 - - - 
EM3O3 - - - 
ASM3W2 - -   -
w
 
A2M3R1 - - - 
A1M3W6 - - - 
A1M3W5 - - - 
A2M3C2 - - - 
A2M3O7 - - - 
A2M3R1  -  - - 
A1M3R4 - - - 
A2M3O6 - - - 
ACM3C1 - - - 
ACM3W1 - - - 
ACM3W5 - - - 
ACM3W7 - - - 
ACM3C8 - - - 
ACM3O13 - -   -
w
 
ACM3W16 - - - 
ACM3W17D - - - 
ACM3W20 - - - 
AGM3Y4 - - - 
w: Weak bacterial growth observed around disk 
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contamination of the culture broth by another microorganism, and further research into 
EMHXC2 was abandoned.  Interestingly, isolates ASM3W2 and ACM3O13 also displayed  
activity against R. erythropolis after 8 days of culture.  However, the activity from these isolates 
was too weak to be of interest.  Another organism isolated from hexadecane enrichment, 
BTHXC6, also initially exhibited activity against M. luteus and R. erythropolis.  Analysis of the 
RM plate streaked from the culture broth revealed multiple colony phenotypes in addition to 
BTHXC6.  BTHXC6 and the contaminant were both re-screened for antibiotic activity, and it 
was found that the contaminant was producing the inhibition against M. luteus and R. 
erythropolis.  Subsequent streak plates isolated 2 different contaminants, designated BTHX1 
and BTHX2.  Isolate BTHX2 exhibited the stronger inhibitory activity, and thus was pursued for 
further study (figure 4).   
 
Characterization of BTHX2 
The 16S rDNA sequence data for BTHX2 showed 97% homology to Bacillus 
licheniformis.  A series of phenotypic assays were then carried out to confirm the identity of 
BTHX2, including staining for the presence of endospores; fermentation of glucose, fructose, 
arabinose, trehalose, and xylose; use of urea, citrate, and hexadecane; hydrolysis of starch and 
gelatin; and growth at different temperature, salt concentrations, and in a pH range of 5 – 10. 
To determine the point of origin of the contaminant BTHX2, the RM slant containing BTHXC6 
was streaked for purity.  As BTHXC6 was isolated using hexadecane enrichment, the ability of 
BTHX2 to use hexadecane as a source of carbon and energy was also tested.  The streak plate of 
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the BTHXC6 slant did not show any contamination.  However, BTHX2 readily used hexadecane 
as the sole source of carbon and energy (table 7). 
 
Figure 4: Inhibitory activity of BTHX1 and BTHX2.  Left plate: M. luteus.  Right plate: R. erythropolis IGTS8.  
Supernatant and cell/resin extract from BTHX1 and BTHX2.   Each disk contains 50 µl of either cell and resin 
extract or supernatant from BTHX1 or BTHX2.  Disk 1 contains extract from BTHX1, and disk 3 contains 
supernatant from BTHX1.  Disk 2 contains extract from BTHX2 and disk 4 contains supernatant from BTHX2.  
Supernatants and extracts were prepared from 50 ml cultures of BTHX1 and BTHX2 grown for 4 days with resin. 
 
 
Table 7: Phenotypic characteristics of BTHX2 
Characteristic Result Characteristic Result Characteristic Result 
Acid from:  Hydrolysis of:  Growth at:  
Glucose + Starch + 5% NaCl + 
Fructose + Gelatin - 7% NaCl + 
Arabinose + Growth at:  10% NaCl + 
Trehalose + 4 
o
C - pH 5 + 
Xylose - 25 
o
C + pH 6 + 
Utilization of: 30 
o
C + pH 7 + 
Citrate - 37 
o
C + pH 8 + 
Urea + 55 
o
C - pH 9 + 
Hexadecane + 2% NaCl + pH 10 + 
 
Thus, the origination of contaminant BTHX2 was unable to be established.  BTHX2 produces 
endospores that are oval in shape, and appear to form near the center of the cell (figure 5).  
BTHX2 readily grew on Simmon‟s Citrate media, but did not produce an alkaline product, as the 
media did not change color.  BTHX2 was able to hydrolyze starch and urea, but not gelatin (table 
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7).  BTHX2 is a mesophile, as it did not grow at 4
o
C or 55
o
C (table 7).  BTHX2 is also 
halotolerant, as it was able to grow in the presence of 10% NaCl (table 7).  In addition, the 
growth of BTHX2 was unaffected by a pH range of 5 – 10, or the presence of oxygen (table 7).  
Interestingly, these phenotypic results rule out the possibility of BTHX2 being a strain of B. 
licheniformis, as BTHX2 does not produce acid from xylose and does not hydrolyze gelatin.  
Moreover, BTHX2 expresses different colony morphology when compared to B. licheniformis 
(figure 6).  In fact, the phenotype of BTHX2 did not match any of the species described in 
Bergey‟s Manual of Systematic Bacteriology.  Thus, at this time it can only be stated 
conclusively that BTHX2 is most genetically similar to B. licheniformis based off of 16S rDNA 
sequence data. 
 
 
Figure 5: Spore stain of BTHX2.  The endospores are stained blue, and vegetative cells are stained  red.  An 
endospore within a vegetative cell is circled.  Left: larger view.  Right: zoomed view of the endospore.  Bottom: 
diagram of zoomed view of endospore.  The endospore forming inside the cell is circled. 
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Figure 6: A comparison of BTHX2 (left) to B. licheniformis (right). 
 
 
XAD-16 Column Purification 
  Another aim of this research was to characterize the inhibitory substance produced by 
BTHX2.  First, BTHX2 was grown in 1 L batches (for a total of 5 L) and extracted as detailed in 
Materials and Methods, and brought up in 40 ml dH2O.  Next, the extract from the 5 L scale up 
was “cleaned” by passage through a column packed with “Amberlite” XAD-16.  The evaporated, 
crude extract was reconstituted in 40 ml of dH2O and poured directly onto the column.  To bind 
the compound to the resin, 1L of ddH2O was passed through the column, and collected in a 2L 
beaker.  Next, the column was washed with 1L of ddH2O, and the material was eluted with 
methanol as the mobile phase.  A total of 13 fractions were collected in 50 ml aliquots.  The 
column was then washed with 1L of methanol, followed by 2L of ddH2O.  All the steps of this 
purification, including washes, flowthrough, and the fractions were tested for antibiotic activity.  
Only fractions 3 – 8 showed inhibitory activity against M. luteus (figure 7).  These fractions were 
evaporated to dryness and pooled using 10 ml methanol.  This „cleaned‟ extract was further 
purified using an LH-20 column. 
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Figure 7: Fractions from BTHX2 extract showing activity from 
XAD-16 column purification. 
 
LH-20 Column Purification 
 The XAD-16 purified extract was passed through an LH-20 column in 2 runs using 5 ml 
aliquots.  The extract was poured directly onto the column, which was run using methanol as the 
mobile phase.  For the 1
st
 run, a total of 47 fractions were collected in 175 drop aliquots.  
Fractions 13 – 21 had activity against M. luteus (figure 8).  For the 2nd run, a total of 45 fractions 
of the same volume were collected, with fractions 15 – 22 showing activity (figure 9).  All the 
active fractions from both runs were pooled and evaporated to dryness, then reconstituted in 2 ml 
of dH2O, yielding a total of 2.8 ml of extract.  An aliquot of 0.8 ml was saved for the purposes of 
testing the extract against a broad range of indicator strains.  The remaining 2 ml was used for 
purification using HPLC. 
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Figure 8: LH-20 fractions from the 1
st
 5 ml aliquot showing inhibitory activity against M. luteus.  Left plate: 
fractions 10 – 18.  Right plate: fractions 19 – 27. 
 
 
 
Figure 9: LH-20 fractions from the 2
nd
 5 ml aliquot showing inhibitory activity against M. luteus.  Left plate: 
fractions 10 – 18.  Right plate: fractions 19 – 27. 
 
 
HPLC Purification 
 The extract from the LH-20 purification was extremely viscous and turbid.  
Centrifugation of the extract at 10,000 rpm for 30 minutes did not remove any precipitants.  
Therefore, the extract was diluted first with 2 ml of ddH2O and second with 9 ml of methanol, 
yielding a 70% methanol solution (13 ml total volume).  The extract was then syringe filtered to 
remove any remaining precipitants and saved in a 15 ml polystyrene tube.  To ensure the 
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inhibitory substance was not contained in the precipitants, the syringe filter was washed with 1 
ml of methanol, and the precipitants were not found to have inhibitory activity.  HPLC was used 
to purify the extract in 2 ml aliquots (as described in Materials and Methods).   The first aliquot 
was purified using a linear gradient of 90% methanol to 100% methanol over 50 ml, which 
resulted in 2 large peaks on the chromatogram (figure 10).  Fractions 23 – 29 exhibited activity 
against M. luteus (figure 11), which corresponded to 93 – 94% methanol (figure 10).  To achieve 
better separation of the inhibitory substance from impurities, another HPLC program was run 
using a gradient of 85% methanol to 95% methanol over the course of 70 ml with a fresh aliquot 
of extract.  This program resulted in 4 peaks, with the inhibitory compound eluting at 87% to 
88% methanol (figure 12, figure 13).  This program was used for the remainder of the extract, 
producing similar results with each run.  Purification using HPLC is continuing. 
 
Figure 10: HPLC chromatogram using the first 2 ml aliquot of LH-20 purified extract. 
 
54 
 
 
Figure 11: Fractions showing activity from 1
st
 HPLC run.  Disks 12, 13, 
14, and 15 represent fractions 23, 25, 27, and 29, respectively. 
 
 
Figure 12: HPLC chromatogram using the second 2 ml aliquot of LH-20 purified extract. 
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Figure 13: Fractions showing activity 2
nd
 HPLC run.  The number on the 
disk is the same as the fraction. 
 
 
Amino Acid Analysis by Thin Layer Chromatography 
 Many of the known antibiotics produced by Bacillus are peptide compounds.  Thus, the 
amino acid content of the inhibitory material analyzed.  To this end, the HPLC purified material 
was acid hydrolyzed, spotted on TLC plate along with the 20 standard amino acids plus 
ornithine, and placed in a TLC chamber containing the solvent system propanol:water (70:30).  
To visualize the amino acids, the TLC plate was developed by spraying first with ninhydrin and 
then with n-cyanoguanidine before incubation at 55
o
C.  Amino acid spots on the plate then were 
visible as red streaks.  The migration of the amino acid standards up the plate were compared 
with the migration of the amino acids in the hydrolyzed sample.  Amino acids matching the 
migration profile of the hydrolyzed sample were run on subsequent TLC plates to confirm the 
match.  Using 70% propanol as the mobile phase, the acid hydrolyzed material appeared to 
contain 4 different amino acids (figure 14). The first two amino acid spots in the sample very 
clearly correspond to glutamic acid and valine.  The third amino acid spot appeared to 
correspond to either leucine or phenylalanine, as both amino acids exhibited similar migration 
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profiles.  The fourth amino acid in the sample migrated much higher up the TLC plate than did 
any of the standards, and the closest match that could be found was tryptophan.  All 5 of these 
amino acids are common in antibiotics. 
 
Figure 14: TLC plate of the acid hydrolyzed sample (arrows) and a narrow range of amino acid standards. 
 
Spectrum of Activity of BTHX2 
 To test the spectrum of the LH-20 purified material, 25 µl aliquots of the 0.8 ml sample 
was applied to paper disks, and placed on MH plates with a broad selection of indicator strains 
(table 8).  The material exhibited no activity against any of the Gram-negative organisms tested.  
However, the extract exhibited activity against most Gram-positive organisms.  For members of 
the genus Bacillus activity was very weak, showing only a few millimeters of inhibition (figure 
15 and table 8).  This was also true for S. aureus and S. epidermidis (figure 15 and table 8).  
Much stronger activity was seen in the members of Actinobacteria tested, especially against M. 
smegmatis (29mm), M. luteus (29mm), Gordonia (37mm), Rhodococcus A2M3O7 (34mm), and 
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C. diphtheria (24mm).  Other bacteria strongly inhibited by the material include all 
Streptococcus tested, Staphylococcus saprophyticus, and Clostridium sporogenes.  The material 
also exhibited antifungal activity against the molds A. niger and P. notatum, but had no activity 
against the yeasts C. albicans and S. cervisiae.  Interesting data were observed when testing the 
inhibitory material against Streptococcus pneumoniae on blood agar (figure 15i).  The growth of 
S. pneumonia is not very visible, but a clear ring of red blood cell hemolysis is seen around the 
disk containing the inhibitory material, suggesting possible cytolytic activity. 
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Figure 15: Inhibitory spectrum of BTHX2 partially purified extract.  Disks containing 25 µl of LH-20 purified 
extract were placed on plates with indicator strains (a – x).  A: S. aureus, zone size: 10 mm; B: S. epidermidis, zone 
size: 12 mm; C: S. saprophyticus, zone size: 28 mm; D: Strep. agalactiae, zone size: 15 mm; E: L. lactis, zone size: 
13 mm; F: M. smegmatis, zone size: 29 mm; G: R. erythropolis, zone size: 15 mm; H: B. cereus, zone size: 13 mm; 
I: Strep. pneumoniae on a blood plate (note the zone of complete hemolysis around the disk), zone size 15 mm; J: B. 
licheniformis, zone size: 10 mm; K: B. megaterium, zone size: 11 mm; L: M. roseus, zone size:19 mm; M: C. 
diphtheriae, zone size: 24 mm; N: M. luteus, zone size: 29 mm; O: S. mutans, zone size: 18 mm; P: S. pyogenes, 
zone size: 17 mm; Q: C. sporogenes, zone size: 17 mm; R: Aeromicrobium SCTEC3, zone size: 27 mm; S: 
Gordonia WDM3O5, zone size: 37 mm; T: Rhodococcus ACM3W20, zone size: 17 mm; U: Rhodococcus 
A2M3R1, 18 mm; V:  Rhodococcus A2M3O7, zone size: 34 mm,       W: A. niger, zone size: 18 mm; X: P. notatum, 
zone size: 20 mm. 
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Table 8: Spectrum of activity of BTHX2 extract 
Organism Gram 
reaction 
Activity Zone size
a
 
Bacillus cereus + + 13 mm 
Bacillus licheniformis + + 10 mm 
Bacillus megaterium + + 11 mm 
Citrobacter freundii - -   
Corynebacterium diphtheriae + + 24 mm 
Clostridium sporogenes + + 17 mm 
Klebsiella pneumoniae - -   
Lactobacillus lactis + + 13 mm 
Micrococcus luteus + + 29 mm 
Micrococcus roseus + + 19 mm 
Mycobacterium smegmatis + + 29 mm 
Neiserria subflava - -   
Proteus vulgaris - -   
Pseudomonas aeruginosa - -   
Pseudomonas denitrificans - -   
Salmonella arizoniae - -   
Salmonella typhi - -   
Shigella boydii - -   
Shigella dysenteriae - -   
Staphylococcus aureus + + 10 mm 
Staphylococcus epidermidis + + 12 mm 
Staphylococcus saprophyticus + + 28 mm 
Streptococcus agalactiae + + 15 mm 
Streptococcus pneumoniae + + 15 mm 
Streptococcus pyogenes + + 17 mm 
Streptococcus mutans + + 18 mm 
Rhodococcus erythropolis + + 15 mm 
Rhodococcus ACM3W20 + + 17 mm 
Rhodococcus A2M3R1 + + 18 mm 
Rhodococcus A2M3O7 + + 34 mm 
Gordonia WDM3O5 + + 37 mm 
Aeromicrobium SCTEC3 + + 27 mm 
Aspergillus niger  Fungus + 18 mm 
Penicillium notatum  Fungus + 20 mm 
Candida albicans  Fungus -   
Saccharomyces cervisiae  Fungus -   
a: size of paper disk containing extract: 7 mm 
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CHAPTER 4 
DISCUSSION 
 Species of the genus Bacillus have been recognized as prolific antibiotic producers since 
the „golden age‟ of antibiotic discovery (Schaffer 1969).  Many antibiotics produced by Bacillus 
species are low molecular weight cyclic polypeptide compounds synthesized either ribosomally 
or non-ribosomally (by non-ribosomal peptide synthases) (Schaffer 1969, Nakano and Zuber 
1990, Stein 2005).  Ribosomally synthesized peptides include lantibiotics such as nisin and 
subtilin, which are active against Gram-positive organisms (Stein 2005).  Bacillomycins and 
mycosubtilin, which are hemolytic and anti-fungal are examples of non-ribosomal peptides 
produced by Bacillus (Stein 2005).  Many of the peptide antibiotics produced by Bacillus contain 
unusual amino acids and are also resistant to proteases (Schaffer 1969).  Two peptide antibiotics 
produced by Bacillus have seen widespread use: bacitracin and polymyxin B.  Bacitracin is a 
cyclic dodecapeptide produced by both B. subtilis and B. licheniformis, and is active mainly 
against Gram-positive organisms by inhibiting cell wall synthesis (Tay et al. 2010).  Bacitracin is 
one of the active ingredients in the topical agents Neosporin and Polysporin, and is also used in 
livestock feed (Tay et al. 2010).  Although this antibiotic has seen 50 years of use, resistance to 
bacitracin is still rare (Tay et al. 2010).  Polymyxin B is part of the polymyxin class of drugs, 
cationic peptides that act against Gram-negative organisms by increasing outermembrane 
permeability (Gales et al. 2001).  In the past polymyxin B was one of the few antibiotics 
effective against P. aeruginosa.  However, other less toxic compounds have been found, and 
polymyxin B is now used as a topical agent (Tay et al. 2001).   Species of Bacillus also produce 
polyketide antibiotics such as difficidin, which has a broad spectrum of activity against Gram-
positive and Gram-negative organisms (Zimmerman et al. 1986). 
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During screening of the 54 identified soil bacteria, BTHX2 – a contaminant from the 
culture broth of BTHXC6 – was found to have inhibitory activity against both R. erythropolis 
IGTS8 and Micrococcus luteus.  BTHX2 16S rDNA is 97% homologous with B. licheniformis.  
Interestingly, BTHX2 differs phenotypically from B. licheniformis, as BTHX2 does not 
hydrolyze gelatin or ferment xylose.  Further phenotypic analysis shows BTHX2 to be 
facultative with regard to the presence of oxygen, mesophilic, and halotolerant, which is 
consistent with B. licheniformis (Logan and De Vos 2009).  Coupled with 16S rDNA data, this 
suggests BTHX2 may be a new strain of B. licheniformis, or perhaps a new species that is very 
closely related to B. licheniformis.  The inhibitory substance produced by BTHX2 was purified 
via column chromatography.  Using HPLC analysis the substance was found to be very 
hydrophobic, as it was soluble only in a solution of 87 – 88% methanol.  The HPLC purified 
material was analyzed for amino acid content and was found to contain four amino acids.  These 
may correspond to glutamic acid, valine, leucine or phenylalanine, and tryptophan.  The LH-20 
purified material was tested against a range of microorganisms.  The substance was not active 
against Gram-negative organisms but had broad spectrum activity against a broad spectrum of 
Gram-positive organisms.  Weak inhibition was observed for species of Bacillus, S. aureus, and 
S. epidermidis.  Against all other bacteria tested strong inhibition was observed, especially for C. 
diphtheriae, M. luteus, M. smegmatis, S. saprophyticus, Rhodococcus sp., Gordonia sp., and 
Aeromicrobium.   The material was also has strong antifungal activity against the molds A. niger 
and P. notatum.  Moreover, the material may exhibit cytolytic activity due to the zone of 
hemolysis observed on the blood plate containing S. pneumoniae.   Future work with this 
substance should include further purification via HPLC and structural analysis, as well as 
optimization of culture conditions and identification of the genes responsible for production of 
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the inhibitory substance.  It would also be interesting to further characterize the inhibitory 
spectrum of BTHX2 against a broader range of Gram-positive organisms and fungi.  It would 
also be worthwhile to characterize the cytolytic activity of the material against eukaryotic cells, 
and to determine  the species of BTHX2. 
 In 2008 the researchers Kitagawa and Tamura tested 80 strains of Rhodococcus for 
antibiotic activity, including many strains of R. erythropolis (Kitagawa and Tamura 2008a).  
They found that 14 R. erythropolis and 1 R. globerulus strain (roughly 19% of all the strains 
tested) produced inhibitory activity.  These 15 organisms were further tested against 52 different 
indicator strains comprising α-, β-, and γ-Proteobacteria, Bacteroidetes, Deinococcus-Thermus, 
Firmicutes, and Actinobacteria.  The Rhodococcus strains were assigned to 3 groups according 
to the inhibitory activity of the antibiotics they produced.  Group 1, comprised of 5 R. 
erythropolis strains, displayed a broad spectrum of activity against Gram-positive organisms.  
Group 2, comprised of 2 R. erythropolis strains and the R. globerulus displayed similar activity 
to group 1 in addition to activity against Rhodococcus.  Group 3, comprised of 7 R. erythropolis 
strains had strong activity against R. erythropolis only.  The compounds produced by groups 1 
and 2 were extracted from the supernatants of their respective strains and partially characterized; 
the compound produced by group 3 could not be extracted from supernatant.  Six months later 
the same researchers reported the characterization of aurachin RE from R. erythropolis strain 
JCM6824, which was one of the group 1 strains (Kitagawa and Tamura 2008b). 
 During this project 54 Gram-positive soil bacteria were isolated by enrichment culture, 
and 37 of these were identified as Rhodococcus via 16S rDNA sequence data.  Kitagawa and 
Tamura found that roughly 19% of the rhodococci they tested produced inhibitory compounds.  
Thus it could be inferred that of the 36 Rhodococcus tested in this project, 6 to 7 would have 
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been expected to produce inhibitory activity.  Unfortunately, none of the organisms isolated by 
enrichment culturing were found to produce inhibitory activity.  Although some Rhodococcus 
were found to inhibit R. erythropolis IGTS8 after 8 days of culturing, this activity was extremely 
weak and therefore characterization of the activity was not pursued further.  These findings were 
unexpected and discouraging, especially considering the success of other interested researchers 
in finding new inhibitory compounds produced by Rhodococcus (Iwatsuki et al. 2007, Kitagawa 
and Tamura 2008b, Kurosawa et al. 2008, Nachtigall et al. 2010).  The work of these research 
groups suggests that Rhodococcus is a good source of antibiotics and that more compounds 
remain to be found from this genus.  Therefore it is appropriate to consider what might have 
gone wrong, and what measures could be taken to overcome potential obstacles in the future. 
 One problem may be the use of only one type of growth media when conducting 
screening experiments.  As discussed in Materials and Methods, all organisms were grown in 50 
ml of RM broth to screen for antibiotic producers.  In addition, culture conditions were not 
varied: all isolates were grown in a 30 
o
C water bath with shaking for 4 days.  When searching 
for new antibiotics, other research groups have used the “One Strain Many Active Compounds” 
approach, where culture conditions are varied in an attempt to induce expression of the 
secondary metabolites.  An excellent example would be Aspergillus ochraceus DSM7428 which 
is a known aspinonene producer (Bode and Müller 2005).  This fungus was grown with complex 
and minimal media, and was grown with shaking and also without shaking (a static culture).  
Using these methods it was found that A. ochraceus produced 15 additional secondary 
metabolites (Bode and Müller 2005).  Although none of these compounds were antibiotics, the 
results show the power of altering media and culture conditions in the quest for new natural 
products from microbes.  In fact, one group of researchers undertook the OSMAC approach with 
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Streptomyces aizunensis NRRL B-11277 (McAlpine et al. 2005).  Streptomyces aizunensis is a 
known producer of bicyclomycin.  Genome scanning revealed 11 other biosynthetic gene 
clusters in addition to the cluster for bicyclomycin biosynthesis.  One cluster was a large type 1 
PKS, the product of which was predicted to be an amidohydroxycyclopentenone.  The research 
group carried out fermentations in 50 different growth media to yield ECO-02301.  Mass 
spectroscopy (MS) and nuclear magnetic resonance (NMR) results revealed that these 
researchers had bioinformatically predicted the structure of the compound.  Although carrying 
out 50 different fermentations for 54 isolated organisms is far beyond the scope of a Masters 
level research, it shows that with patience, hard work and determination the OSMAC method can 
prove fruitful with the prior knowledge of an orphan biosynthetic pathway.  Moreover, other 
researchers in this lab have found inhibitory activity from the Rhodococcus strains isolated 
during this project by attemping different screening techniques.   
 Heterologous expression could also be useful for tapping into the orphan biosynthetic 
gene clusters of Rhodococcus.  Although Rhodococcus harbors the biosynthetic machinery for 
polyketides and non-ribosomal peptides, specific components may be missing, such as starter 
units for the pathway.  Cloning the PKSs and NRPSs of Rhodococcus into a related organism 
known to produce antibiotics such as Streptomyces could provide an avenue of novel bioactive 
metabolites.  Transfer of a PKS or NRPS has not yet been reported for Rhodococcus but has been 
performed successfully in other actinomycetes, such as Streptomyces (Bode and Müller 2005, 
Gross 2009).  Moreover, rhodococcal PKSs and NRPSs could be expressed in other 
Rhodococcus strains reported to produce antibiotics (described previously).  The 
rhodostreptomycins produced by R. fascians 307C0 are thought to be the product of horizontal 
gene transfer from Streptomyces padanus (Kurosawa et al. 2008).  Interestingly, the 
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rhodostreptomycins are aminoglycoside compounds, and differ greatly from the actinomycin 
antibiotics produced by S. padanus.  This suggests that the introduction of biosynthetic 
machinery from other Streptomyces (or other Actinobacteria) into Rhodococcus may bear fruit 
for the discovery of novel bioactive compounds. 
 
66 
 
 
REFERENCES 
 
Ascenzi P, Clementi E, Polticelli F. 2003. The Rhodococcus sp. cocaine esterase: a bacterial 
 candidate for novel pharmacokinetic-based therapies for cocaine abuse.  International 
  Union of Biochemistry and Molecular Biology Life. 55: 397 – 402. 
Bad bugs, no drugs: as antibiotic R&D stagnates, a public health crisis brews.  Alexandria, VA:  
Infectious Diseases Society of America, 2004. 
Baltz RH.  2007. Antimicrobials from actinomycetes: back to the future.  Microbe.  2: 125 – 
 131. 
Bell KS, Philp JC, Aw DWJ and Christofi N. 1998.  The genus Rhodocococcus.  Journal of 
 Applied Microbiology  85: 195 – 210. 
Bode HB, Müller R. 2005. The impact of bacterial genomics on natural product research.   
Angewandte de Chemie.  44: 6828 – 6846. 
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B,  
Bartlett J.  2009.  Bad Bugs, No Drugs: No ESKAPE!  An update from the Infectious 
Diseases Society of America.  Clinical Infectious Diseases.  48: 1 – 12  
Cameron GWW, Jordan KN, Holt P, Baker PB, Lowe CR, Bruce NC. 1994. Identification of a 
 heroin esterase in Rhodococcus sp. strain H1.  Applied and Environmental Microbiology. 
  90: 3881 – 3883. 
Chiba H, Agematu H, Kaneto R, Terasawa T, Sakai K, Kazuyuki D, Yoshioka T. 1999. 
 Rhodopeptins (Mer-N1033), novel cyclic tetrapeptides with antifungal activity from 
 Rhodococcus sp.  I. taxonomy, fermentation, isolation, physico-chemical properties and 
 biological activities.  The Journal of Antibiotics.  52: 695 – 699. 
67 
 
Civilini M. 2009. Identification and characterization of bacteria isolated under selective pressure 
 of volatile organic compounds.  Journal of  Environmental Biolology.  30: 99 – 105. 
de Carvalho CCCR, da Fonseca MMR. 2005. The remarkable Rhodococcus erythropolis.  
 Applied Microbiology and Biotechnology.  67: 715 – 726. 
Demain AL, Sanchez S. 2009. Microbial drug discovery: 80 years of progress.  The Journal of  
Antibiotics.  52: 5 – 16. 
Dischinger J, Josten M, Szekat C, Sahl H, Bieberbaum G. 2009.  Production of the novel two-
 peptide  lantibiotic lichenicidin by Bacillus licheniformis DSM 13.  Public Library of 
 Science ONE.  4: 1 – 11. 
Floss HG. 2006. Combinatorial biosynthesis – potential and problems.  Journal of 
 Biotechnology.  124: 242 – 257. 
Gales A, Reis A, Jones R. 2001. Contemporary assessment of antimicrobial susceptibiligy testing 
 methods for polymyxin B and colistin: review of available interpretative criteria and 
 quality control guidelines.  Journal of Clinical Microbiology.  39: 183 – 190. 
Garcia RO, Krug D, Müller R. 2009. Discovering natural products from Myxobacteria with  
 emphasis on rare producer strains in combination with improved analytical methods.  
 Methods in Enzymology.  458: 59 – 91. 
Gauthier H, Yargeau V, Cooper DG. 2010. Biodegradation of pharmaceucticals by Rhodococcus  
rhodochrous and Aspergillus niger by co-metabolism.  Science of the Total Environment   
408: 1701 – 1706. 
Goethals K, Vereecke D, Jaziri M, Van Montagu M, Holsters M. 2001. Leafy gall formation by  
Rhodococcus fascians.  Annual Review of Phytopathology .  39: 27 – 52. 
68 
 
Goodfellow M. 1989. Bergey‟s Manual of Systematic Bacteriology.  Philadelphia, PA: Williams 
and Wilkins.  Section 26: nocardioform actinomycetes – Genus Rhodococcus. 2362-2371 
Gross H. 2009. Genomic mining – a concept for the discovery of new bioactive natural products. 
Current Opinion in Drug Discovery & Development.  12: 207 – 219 
Iwatsuki M, Uchida R, Takakusagi Y, Matsumoto A, Jiang C, Takahashi Y, Arai M, Kobayashi  
S, Matsumoto M, Inokoshi J, Tomoda H, Omura S. 2007. Lariatins, Novel anti-
mycobacterial peptides with a lasso structure, produced by Rhodococcus jostii K01-
B0171. The Journal of Antibiotics.  60: 357 – 363. 
Jung-Bok L, Sohn H, Shin K, Jo M, Jeon C, Jang J, Kim J, Kwon G. 2008.  Microbial 
 biodegradation and toxicity of vinclozolin and its toxic metabolite 3,5-dichloroaniline.  
  Journal of Microbiology and Biotechnology.  18: 343 – 349. 
Kitagawa W, Tamura T. 2008 a. Three types of antibiotics produced from Rhodococcus 
 erythropolis  strains.  Microbes and Environments. 23: 167 – 171. 
Kitagawa W, Tamura T. 2008 b. A quinoline antibiotic from Rhodococcus erythropolis JCM 
 6824.  The Journal of Antibiotics. 61: 680 – 682. 
Kurosawa K, Ghiviriga I, Sambandan TG, Lessard PA, Barbara JE, Rha C, Sinskey AJ. 2008.  
Rhodostreptomycins, antibiotics biosynthesized following horizontal gene transfer from 
Streptomyces padanus to Rhodococcus fascians.  Journal of the American Chemical 
Society.  130: 1126 – 1127. 
Li JWH, Vederas JC. 2009. Drug Discovery and Natural Products: End of an Era or an Endless  
Frontier?  Science.  325: 161 – 165. 
69 
 
Liu X, Ashforth E, Ren B, Song F, Dai H, Liu M, Wang J, Xie Q, Zhang L. 2010. 
 Bioprospecting microbial natural product libraries from the marine environment for drug 
 discovery.  The Journal of Antibiotics.  63: 415 – 422.  
Logan N, De Vos P. 2009.  Bergey‟s Manual of Systematic  Bacteriology.  New York, NY: 
 Springer Science. Genus I. Bacillus. 3: 21-128 
Marchesi JR, Sato T, Weightman AJ, Martin TA, Fry JC, Hiom S, Wade W. 1998. Design and  
evaluation of useful bacterium-specific PCR primers that amplify genes coding for 
bacterial 16S rRNA.  Applied and Environmental Microbiology . 64: 795 – 799. 
McAlpine JB, Bachmann BO, Piraee M, Tremblay S, Alarco A, Zazopoulos E, Farnet CM. 2005. 
 Microbial genomics as a guide to drug discovery and structural elucidation: ECO-  
 02301, a novel antifungal agent, as an example.  Journal of Natural Products.  68:  493 – 
 496. 
McLeod M, Warren R, Hsiao W, Araki N, Myhre M, Fernandes C, Miyazawa D, Wong W,  
Lillquist A, Wang D, Dosanjh M, Hara H, Petrescu A, Morin R, Yang G, Stott J, Schein 
J, Shin H, Smailus D, Siddiqui A, Marra M, Jones S, Holt R, Brinkman F, Miyauchi K, 
Fukuda M, Davies J, Mohn W, Eltis L. 2006. The complete genome of Rhodococcus sp. 
RHA1 provides insights into a catabolic powerhouse. Proceedings of the National 
Academy of Science USA.  103: 15582 – 15587. 
Nachtigall J, Schneider K, Nicholson G, Goodfellow M, Zinecker H, Imhoff JF, Sussmuth RD,  
Fiedler H. 2010. Two new aurachins from Rhodococcus sp. Acta 2259.  The Journal of 
Antibiotics.  63: 567 – 569. 
Nagashima K, Hisada T, Sato M, Mochizuki J. 2003. Application of new primer-enzyme 
 combinations to terminal restriction fragment length polymorphism profiling of bacterial 
70 
 
 populations in human feces.  Applied and Environmental Microbiology.  69: 1251 – 
 1262. 
Nakamiya K, Nakayama T, Ito H, Shibata Y, Morita M. 2008. Isolation and properties of a 2- 
chlorovinylarsonic acid-degrading microorganism.  Journal of Hazardous Materials.  165: 
388 – 393. 
Nakano M, Zuber P. 1990. Molecular biology of antibiotic production in Bacillus.  Critical 
  Reviews in Biotechnology.  10: 223 – 240. 
Ohhata N, Yoshida N, Egami H, Katsuragi T, Tani Y, Takagi H. 2007. An extremely 
 oligotrophic bacterium, Rhodococcus erythropolis N9T-4, isolated from crude oil.  
 Journal of Bacteriology.  189: 9824 – 6831. 
Owens RC. 2008. Antimicrobial stewardship: concepts and strategies in the 21
st
 century.  
 Diagnostic Microbiology and Infectious Disease.  61: 110 – 128. 
Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL. 2007. Drugs for bad bugs: confronting the  
challenges of antibacterial discovery.  Nature Reviews . 6: 29 – 40. 
Peng F, Liu Z, Wang L, Shao Z. 2006. An oil-degrading bacterium: Rhodococcus erythropolis 
 strain 3C-9 and its biosurfactants.  Journal of Applied Microbiology.  102: 1603 – 1611.  
Projan SJ. 2003. Why is big Pharma getting out of antibacterial drug discovery?  Current 
 Opinion in Microbiology.  6: 427 – 430. 
Rivas R, Velázquez E, Valverde A, Mateos P, Martínez-Molina. 2001. A two primers random  
amplified polymorphic DNA procedure to obtain polymerase chain reaction fingerprints 
of bacterial species.  Electrophoresis .  22: 1086 – 1089. 
Rice LB. 2008. Federal funding for the study of antimicrobial resistance in nosocomial 
 pathogens: no ESKAPE.  Journal of Infectious Diseases  197: 1079 – 1081. 
71 
 
Rokem SJ, Lantz AE, Nielsen J. 2007.  Systems biology of antibiotic production by 
 microorganisms.  Natural Product Reports.   24: 1262 – 1287. 
Rossolini GM, Thaller MC. 2010. Coping with antibiotic resistance: contributions from 
 genomics.  Genome Medicine. 2: 15. 
Rowbotham TJ, Cross T. 1977. Ecology of Rhodococcus coprophilus and associated 
 actinomycetes in fresh water and agricultural habitats.  Journal of General Microbiology. 
 100: 231 – 240. 
Schaffer P. 1969. Sporulation and the production of antibiotics, exoenzymes, and exotoxins.  
 Bacteriological Reviews.  33: 48 – 71. 
Seth-Smith HMB, Edwards J, Rosser SJ, Rathbone DA, Bruce NC. 2008. The explosive-
 degrading cytochrome P450 system is highly conserved among strains of Rhodococcus 
 spp.  Applied and Environmental Microbiology.  74: 4550 – 4552. 
Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J.   
2008. The Epidemic of Antibiotic-Resistant Infections: A call to Action for the Medical 
Community from the Infectious Diseases Society of America.  Clinical Infectious 
Diseases.  46: 155 – 164  
Stein T. 2005 Bacillus subtilis antibiotics: structures, syntheses, and specific functions. 
 Molecular Microbiology.  56: 845 – 857. 
Storey E.  2005.  Characterization of a dihydroxamate-type siderophore produced by 
 Rhizobium leguminosarum IARI 917: is it schizokinen?  M. S. Thesis.  East Tennessee 
  State  Univeristy, Johnson City, TN. 
Tay W, Epperson J, da Silva G, Ming L. 2010. 
1
H NMR, mechanism, and mononuclear oxidative 
 activity of the antibiotic metallopeptide bacitracin: the role of D-glu-4, interaction with 
72 
 
 pyrophosphate moiety, DNA binding and cleavage, and bioactivity.  Journal of the 
 American Chemical Society.  132: 5652 – 5661. 
Tischler D, Eulberg D, Lakner S, Kaschabek SR, van Berkel WJH, Schlomann M. 2009.  
  Identification of a novel self-sufficient styrene monooxygenase from Rhodococcus 
 opacus 1CP.  Journal of Bacteriology.  191: 4996 – 5009. 
von Bargen K, Haas A. 2009. Molecular and infection biology of the horse pathogen 
 Rhodococcus equi.  Federation of European Microbiological Societies Microbiology 
 Reviews . 33: 870 – 891. 
Wright W.  2010. Isolation and identification of the siderophore “vicibactin” produced by 
 Rhizobium leguminosarum ATCC 14479.  M. S. Thesis.  East Tennessee State 
 University, Johnson City, TN. 
Zimmerman S, Schwartz C, Monaghan R, Pelak B, Weissberger B, Gilfillan E, Mochales S, 
 Hernandez S, Currie S, Tejera E, Stapley E. 1987.  Difficidin and oxydifficidin: novel 
 broad spectrum antibacterial antibiotics produced by Bacillus subtilis. I. Production, 
 taxonomy and antibacterial activity.  The Journal of Antibiotics.  40: 1677 – 1681. 
73 
 
VITA 
 
THOMAS S. BARBER 
 
 
 
Personal Data:   Date of Birth: February 20, 1983 
    Place of Birth: Kingsport, Tennessee 
    Marital Status: Single 
 
Education:   Sullivan South High School, Kingsport, Tennessee 2001 
    B. S. Microbiology, East Tennessee State University, Johnson  
     City, Tennessee 2008 
    M. S. Biology, conc. Microbiology, East Tennessee State   
     University, Johnson City, Tennessee 2010 
 
Professional Experience:  Research Tech I, East Tennessee State University, College of  
     Public and Allied Health, 2008 
    Graduate Assistant, East Tennessee State University, College of  
     Public Health, 2008 – 2010 
 
Presentations:  Barber T, Lampson B.  Screening the soil bacterium Rhodococcus 
 for antibiotic producers (2009).  Abstract, American 
 Society for Microbiology  Kentuck/Tennessee Branch 
 Conference in  Knoxville, Tennessee 
 
    Barber T, Lampson B.  Screening the soil bacterium Rhodococcus  
    for antibiotic producers (2010).  Abstract, ETSU   
    Appalachian Student Research Forum in Johnson City,  
    Tennessee. 
 
Preparation:    Barber T.  2010.  Screening the soil bacterium Rhodococcus for  
     antibiotic producers.  M. S. Thesis.  East Tennessee State  
     University, Johnson City, TN. 
